Personalized Medicine Biomarkers Market 2025 to 2034
Personalized Medicine Biomarkers Market 2025 to 2034
Personalized Medicine Biomarkers Market (By Application: Early Detection/Screening, Diagnosis, Treatment Selection, Monitoring; By Indication: Oncology, Neurology, Diabetes, Autoimmune Diseases, Cardiology, Others; By Region: North America, LAMEA, Europe, Asia-Pacific) - Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2025 to 2035
Customisation Request
Revenue, 2024
USD 19.05
Forecast Year, 2034
USD 82.08 Bn
CAGR, 2025 - 2034
15.73%
Report Coverage
Worldwide
Published By
Saurabh Bidwai
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
The global personalized medicine biomarkers market, valued at USD 19.05 billion in 2024, is projected to surge to USD 82.08 billion by 2034, expanding at a robust CAGR of 15.73% driven by advancements in targeted therapies and precision diagnostics.
Personalized Medicine Biomarkers Market Size Analysis
Personalized Medicine Biomarkers Market Size By Application 2025 to 2034 (USD Billion)
| Application | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Early Detection/Screening | 2.21 | 2.56 | 2.95 | 3.43 | 3.97 | 4.57 | 5.36 | 6.13 | 7.15 | 8.29 |
| Diagnosis | 4.39 | 5.12 | 5.91 | 6.85 | 7.90 | 9.18 | 10.64 | 12.27 | 14.22 | 16.47 |
| Treatment Selection | 6.63 | 7.66 | 8.88 | 10.24 | 11.88 | 13.71 | 15.83 | 18.39 | 21.31 | 24.58 |
| Monitoring | 8.82 | 10.18 | 11.79 | 13.66 | 15.81 | 18.30 | 21.15 | 24.51 | 28.26 | 32.76 |
Personalized Medicine Biomarkers Market Size By Indication 2025 to 2034 (USD Billion)
| Indication | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Oncology | 1.05 | 1.22 | 1.42 | 1.65 | 1.91 | 2.18 | 2.54 | 2.96 | 3.38 | 3.92 |
| Neurology | 2.11 | 2.43 | 2.81 | 3.27 | 3.78 | 4.36 | 5.06 | 5.86 | 6.77 | 7.86 |
| Diabetes | 3.16 | 3.65 | 4.23 | 4.88 | 5.65 | 6.53 | 7.55 | 8.74 | 10.13 | 11.71 |
| Autoimmune Diseases | 4.19 | 4.86 | 5.63 | 6.52 | 7.52 | 8.73 | 10.07 | 11.67 | 13.51 | 15.65 |
| Cardiology | 5.24 | 6.06 | 7.02 | 8.13 | 9.41 | 10.91 | 12.61 | 14.58 | 16.87 | 19.50 |
| Others | 6.30 | 7.29 | 8.41 | 9.74 | 11.28 | 13.05 | 15.13 | 17.50 | 20.29 | 23.46 |
Personalized Medicine Biomarkers Market Size By Region 2025 to 2034 (USD Billion)
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| North America | 2.21 | 2.54 | 2.98 | 3.41 | 4.00 | 4.62 | 5.35 | 6.13 | 7.08 | 8.29 |
| LAMEA | 4.42 | 5.11 | 5.90 | 6.86 | 7.87 | 9.19 | 10.55 | 12.33 | 14.27 | 16.46 |
| Europe | 6.61 | 7.66 | 8.87 | 10.24 | 11.87 | 13.67 | 15.90 | 18.37 | 21.28 | 24.58 |
| Asia-Pacific | 8.80 | 10.20 | 11.78 | 13.67 | 15.81 | 18.29 | 21.17 | 24.47 | 28.31 | 32.78 |
Personalized Medicine Biomarkers Market Size to Hit USD 82.08 Billion by 2034
The global personalized medicine biomarkers market size surpassed USD 19.05 billion in 2024 and is predicted to reach around USD 82.08 billion by 2034 with a registering a CAGR of 15.73%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
